Methodology

All entries for: Galapagos NV

June 16, 2026

Galapagos NV

Orphan Drug Designation

Mechelen, Belgium

1,001-5,000 employees

treatment of dermatomyositis

Disease Area: Rare Diseases

March 26, 2026

Galapagos NV

Neutral Outlook

Mechelen, Belgium

1,001-5,000 employees

The effects of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Immune Diseases, Oncology

Drug Type: Small Molecule